Ambu downgrades, will cut costs
![Photo: PR / Ambu](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14109631.ece/ALTERNATES/schema-16_9/doc7lbwy6m6bf62y595de3.jpg)
On Wednesday, Danish medtech firm Ambu announced preliminary financial figures from the third quarter of fiscal 2021/2022 – alongside a guidance downgrade for the full-year and a cost reduction program meant to result in DKK 250m (USD 34.1m) annualized savings.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA clears Ambu's new bronchoscope generation
For subscribers
Britt Meelby Jensen wants to rebuild trust in Ambu
For subscribers